Genelux Corporation revenue breakdown overview

Genelux Corporation revenue for the last year amounted to 8.00 k USD, the most of which — 8.00 k USD — came from its highest performing source at the moment, Oncolytic Immunotherapies, the year earlier bringing 170.00 k USD. The greatest contribution to the revenue figure was made by United States — last year it brought Genelux Corporation 8.00 k USD, and the year before that — 170.00 k USD.